The MFDS evaluates pharmacovigilance data by assessing adverse event reports, periodic safety update reports (PSURs), and risk management plans (RMPs). They analyze the benefit-risk profile, monitor drug safety trends, and may request additional safety studies. This process helps ensure ongoing drug safety and prompt action if new risks emerge.